- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.65 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x TZD: 2-{3-[(4-AMINO-2-METHYLPYRIMIDIN-5-YL)METHYL]-4-METHYL-2-OXO-2,3-DIHYDRO-1,3-THIAZOL-5-YL}ETHYL TRIHYDROGEN DIPHOSPHATE(Non-covalent)
- 4 x CA: CALCIUM ION(Non-covalent)
CA.2: 4 residues within 4Å:- Chain A: D.427, N.454, T.456
- Ligands: TZD.1
3 PLIP interactions:2 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:D.427, A:T.456, H2O.1
CA.13: 4 residues within 4Å:- Chain B: D.427, N.454, T.456
- Ligands: TZD.12
3 PLIP interactions:2 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:D.427, B:T.456, H2O.18
CA.24: 4 residues within 4Å:- Chain C: D.427, N.454, T.456
- Ligands: TZD.23
3 PLIP interactions:2 interactions with chain C, 1 Ligand-Water interactions- Metal complexes: C:D.427, C:T.456, H2O.34
CA.35: 4 residues within 4Å:- Chain D: D.427, N.454, T.456
- Ligands: TZD.34
3 PLIP interactions:2 interactions with chain D, 1 Ligand-Water interactions- Metal complexes: D:D.427, D:T.456, H2O.51
- 36 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.3: 8 residues within 4Å:- Chain A: W.85, N.86, H.88, P.275, D.300, E.303, R.306
- Chain B: E.106
Ligand excluded by PLIPEDO.4: 7 residues within 4Å:- Chain A: A.148, P.149, V.182, C.299, V.314, A.315
- Ligands: EDO.26
Ligand excluded by PLIPEDO.5: 5 residues within 4Å:- Chain A: N.214, A.215, N.216, A.217, D.218
Ligand excluded by PLIPEDO.6: 10 residues within 4Å:- Chain A: A.47, G.79, A.80, N.83, G.401, L.402, G.403
- Chain B: A.72, N.76
- Ligands: TZD.1
Ligand excluded by PLIPEDO.7: 4 residues within 4Å:- Chain A: G.255, I.256, A.257, A.258
Ligand excluded by PLIPEDO.8: 6 residues within 4Å:- Chain A: Q.413, P.417, E.418, R.419, Q.420, P.446
Ligand excluded by PLIPEDO.9: 4 residues within 4Å:- Chain A: K.495, Q.501, G.504, S.505
Ligand excluded by PLIPEDO.10: 6 residues within 4Å:- Chain A: R.119, W.124, S.125, Y.126, R.140
- Chain D: V.112
Ligand excluded by PLIPEDO.11: 2 residues within 4Å:- Chain A: A.1, D.165
Ligand excluded by PLIPEDO.14: 8 residues within 4Å:- Chain A: E.106
- Chain B: W.85, N.86, H.88, P.275, D.300, E.303, R.306
Ligand excluded by PLIPEDO.15: 7 residues within 4Å:- Chain B: A.148, P.149, V.182, C.299, V.314, A.315
- Ligands: EDO.37
Ligand excluded by PLIPEDO.16: 5 residues within 4Å:- Chain B: N.214, A.215, N.216, A.217, D.218
Ligand excluded by PLIPEDO.17: 10 residues within 4Å:- Chain A: A.72, N.76
- Chain B: A.47, G.79, A.80, N.83, G.401, L.402, G.403
- Ligands: TZD.12
Ligand excluded by PLIPEDO.18: 4 residues within 4Å:- Chain B: G.255, I.256, A.257, A.258
Ligand excluded by PLIPEDO.19: 6 residues within 4Å:- Chain B: Q.413, P.417, E.418, R.419, Q.420, P.446
Ligand excluded by PLIPEDO.20: 4 residues within 4Å:- Chain B: K.495, Q.501, G.504, S.505
Ligand excluded by PLIPEDO.21: 6 residues within 4Å:- Chain B: R.119, W.124, S.125, Y.126, R.140
- Chain C: V.112
Ligand excluded by PLIPEDO.22: 2 residues within 4Å:- Chain B: A.1, D.165
Ligand excluded by PLIPEDO.25: 8 residues within 4Å:- Chain C: W.85, N.86, H.88, P.275, D.300, E.303, R.306
- Chain D: E.106
Ligand excluded by PLIPEDO.26: 7 residues within 4Å:- Chain C: A.148, P.149, V.182, C.299, V.314, A.315
- Ligands: EDO.4
Ligand excluded by PLIPEDO.27: 5 residues within 4Å:- Chain C: N.214, A.215, N.216, A.217, D.218
Ligand excluded by PLIPEDO.28: 10 residues within 4Å:- Chain C: A.47, G.79, A.80, N.83, G.401, L.402, G.403
- Chain D: A.72, N.76
- Ligands: TZD.23
Ligand excluded by PLIPEDO.29: 4 residues within 4Å:- Chain C: G.255, I.256, A.257, A.258
Ligand excluded by PLIPEDO.30: 6 residues within 4Å:- Chain C: Q.413, P.417, E.418, R.419, Q.420, P.446
Ligand excluded by PLIPEDO.31: 4 residues within 4Å:- Chain C: K.495, Q.501, G.504, S.505
Ligand excluded by PLIPEDO.32: 6 residues within 4Å:- Chain B: V.112
- Chain C: R.119, W.124, S.125, Y.126, R.140
Ligand excluded by PLIPEDO.33: 2 residues within 4Å:- Chain C: A.1, D.165
Ligand excluded by PLIPEDO.36: 8 residues within 4Å:- Chain C: E.106
- Chain D: W.85, N.86, H.88, P.275, D.300, E.303, R.306
Ligand excluded by PLIPEDO.37: 7 residues within 4Å:- Chain D: A.148, P.149, V.182, C.299, V.314, A.315
- Ligands: EDO.15
Ligand excluded by PLIPEDO.38: 5 residues within 4Å:- Chain D: N.214, A.215, N.216, A.217, D.218
Ligand excluded by PLIPEDO.39: 10 residues within 4Å:- Chain C: A.72, N.76
- Chain D: A.47, G.79, A.80, N.83, G.401, L.402, G.403
- Ligands: TZD.34
Ligand excluded by PLIPEDO.40: 4 residues within 4Å:- Chain D: G.255, I.256, A.257, A.258
Ligand excluded by PLIPEDO.41: 6 residues within 4Å:- Chain D: Q.413, P.417, E.418, R.419, Q.420, P.446
Ligand excluded by PLIPEDO.42: 4 residues within 4Å:- Chain D: K.495, Q.501, G.504, S.505
Ligand excluded by PLIPEDO.43: 6 residues within 4Å:- Chain A: V.112
- Chain D: R.119, W.124, S.125, Y.126, R.140
Ligand excluded by PLIPEDO.44: 2 residues within 4Å:- Chain D: A.1, D.165
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Brodkin, H.R. et al., Crystal Structure of the His281Thr mutant of Benzoylformate Decarboxylase from Pseudomonas putida. To be Published
- Release Date
- 2013-05-08
- Peptides
- Benzoylformate decarboxylase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.65 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x TZD: 2-{3-[(4-AMINO-2-METHYLPYRIMIDIN-5-YL)METHYL]-4-METHYL-2-OXO-2,3-DIHYDRO-1,3-THIAZOL-5-YL}ETHYL TRIHYDROGEN DIPHOSPHATE(Non-covalent)
- 4 x CA: CALCIUM ION(Non-covalent)
- 36 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Brodkin, H.R. et al., Crystal Structure of the His281Thr mutant of Benzoylformate Decarboxylase from Pseudomonas putida. To be Published
- Release Date
- 2013-05-08
- Peptides
- Benzoylformate decarboxylase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A